Clinical Trial: A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404137) titled 'A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food' on Feb. 05.

Brief Summary: The purpose of this study is to investigate the concentrations of zibotentan and dapagliflozin in blood when given with and without food in healthy participants.

Study Start Date: Feb. 11

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Zibotentan/Dapagliflozin FDC

Zibotentan/Dapagliflozin FDC will be administered as an oral tablet.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....